Hypertension prevalence and cascade of care in Iran: Updates from the STEPs 2021 national and subnational survey
Author:
Heidari-Foroozan Mahsa1, Rezaei Negar1, Malekpour Mohammad-Reza1, Behnoush Amir Hossein1, Ahmadi Naser1, Abbasi-Kangevari Mohsen1, Masinaei Masoud1, Azadnajafabad Sina1, Ghamari Seyyed-Hadi1, Rashidi Mohammad-Mahdi1, Keykhaei Mohammad2, Golestani Ali1, Ghasemi Erfan1, Farzi Yosef1, Rezaei Nazila1, Yoosefi Moein1, Abdolhamidi Elham1, Haghshenas Rosa1, Nasserinejad Maryam3, Daneshmand Mojdeh4, Kazemi Ameneh1, Moghaddam Sahar Saeedi5, Rankohi Azadeh Momen Nia1, Djalalinia Shirin6, Farzadfar Farshad7
Affiliation:
1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences 2. The Johns Hopkins University School of Medicine 3. University of Oulu 4. Shahid Beheshti University of Medical Science 5. Kiel Institute for the World Economy 6. Ministry of Health and Medical Education 7. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences
Abstract
Abstract
Background
Hypertension (HTN) is rising worldwide. Accurate information about its prevalence, diagnosis, coverage, and control is essential for policymakers to implement effective strategies.
Method
Data were gathered from the nationally representative Iran STEPs 2021 study. ANOVA- test and chi-square were used to compare the prevalence, diagnosis, coverage, and control across the groups. Data were age-standardized. Multiple logistic regression with adjustments was performed. We also used the concentration index with concerning wealth index levels and schooling years.
Results
When using JNC8 guidelines, 32.0% (95% CI: 31.4–32.6), of Iranian adults suffered from HTN and it was more common in women (32.9% (32.1–33.8)) in comparison to men (30.9% (30-31.8)). While prevalence, diagnosis, and coverage were substantially dependent on factors such as socioeconomic status, lifestyle, age, and underlying diseases, control was independent of most of the measured variables. The distributions of HTN prevalence, diagnosis, and treatment were more concentrated in lower wealth index and years of schooling.
Conclusion
The prevalence of HTN in Iran is still high. Due to the grave consequences of hypertension, with it being a major direct and indirect cause of mortality, nationwide strategies to control its uprising prevalence are vital.
Publisher
Research Square Platform LLC
Reference52 articles.
1. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1223-49. 2. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018;392(10159):1923-94. 3. hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants;Worldwide trends in;Lancet (London, England),2021 4. Global burden of hypertension: analysis of worldwide data;Kearney PM;Lancet (London, England),2005 5. Organization WH. Noncommunicable disease facility-based monitoring guidance: framework, indicators and application: World Health Organization; 2022.
|
|